Oscar Health, Inc. Q3 2025 Earnings Recap

OSCR Q3 2025 November 7, 2025

Get alerts when OSCR reports next quarter

Oscar Health reported a 23% year-over-year increase in revenue for Q3 2025, although losses widened due to higher market morbidity. The company remains optimistic about profitability improvements in 2026.

Earnings Per Share Beat

$-0.53 vs $-0.55 est.

+3.6% surprise

Revenue Miss

2985984000 vs 3052441640 est.

-2.2% surprise

Market Reaction

1-Day +7.0%

5-Day -8.82%

30-Day +1.75%

See OSCR alongside your other holdings

Add to your portfolio — free

Key Takeaways

Total revenue reached approximately $3 billion, with an adjusted EBITDA loss of $101 million.
Membership increased by 28% year-over-year, surpassing 2 million members.
The company implemented a disciplined pricing strategy for 2026, with a weighted average rate increase of about 28%.
New innovative products, including HelloMeno, are designed to capture additional market share and cater to women's health.
Oscar is integrating an AI health agent, Oswell, across its product offerings to enhance member engagement and support.

This summary was generated by AI from the official earnings call transcript and is provided for informational purposes only. It does not constitute financial advice. For the complete transcript and financial data, visit OSCR on AllInvestView.

Next Q1 2026